Lepercq De Neuflize Asset Management LLC 13D and 13G filings for Bellerophon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 10:46 am Purchase |
2023-12-18 | 13G | Bellerophon Therapeutics, Inc. BLPH |
Lepercq De Neuflize Asset Management LLC | 1,026,868 8.400% |
1,026,868 (New Position) |
Filing |